Funded Startups in Marlborough
Among the 17 Marlborough-based entries shown (sorted by round date), Solid Biosciences’ $200M raise on 2025-02-18 is an outlier: it is the only disclosed r…
Among the 17 Marlborough-based entries shown (sorted by round date), Solid Biosciences’ $200M raise on 2025-02-18 is an outlier: it is the only disclosed round above $50M, while the rest cluster between $900K and $33M (with several much smaller rounds such as Special Olympics Massachusetts at $10K on 2023-07-12). Sector and stage patterns are also clear—biotechnology is the largest sector grouping, appearing in 7 of 17 companies (Solid Biosciences, Phio Pharmaceuticals, DNAiTECH, AssayQuant Technologies, Akoya Biosciences, Meadowhawk Biolabs, and others). Chronologically, the list is front-loaded: 7 of the 17 rounds occurred from 2024-09-19 through 2025-06-25, and the disclosed amounts generally sit in the same mid-to-high single digit to tens of millions range, except for the $200M and $10K bookends.
The temporal span runs from 2021-09-27 (Rewalk Robotics, Post-IPO Equity, $33M) through 2025-06-25 (Lifeward, Series Unknown, $3M). Most entries carry “Series Unknown” in the round classification (13 of 17), which makes the dominant stage mix harder to infer beyond the smaller number of explicit labels (e.g., LiquidStack’s Series B on 2024-09-19 at $20M, OneShield Software’s Venture - Series Unknown on 2022-01-27 at $50M, and Main Street Bank’s Debt Financing on 2021-12-03 at $25M).
Most recent rounds
17 shownRelated listings
Frequently asked
Which disclosed round is the clear outlier in Marlborough, and how does it compare to the rest of the list?
Solid Biosciences’ $200M on 2025-02-18 dwarfs the next-largest disclosed amount at $50M (OneShield Software on 2022-01-27), and it is the only disclosed round above $50M. At the other extreme, Special Olympics Massachusetts is the smallest disclosed entry at $10K on 2023-07-12.
How concentrated are rounds in the most recent time window shown?
There is a tight cluster near the top of the list: 7 of the 17 rounds fall between 2024-09-19 (LiquidStack) and 2025-06-25 (Lifeward). Within that window, amounts range from $1M (Phio Pharmaceuticals on 2024-12-19) up to $200M (Solid Biosciences on 2025-02-18).
Are any sectors over-represented among Marlborough’s funded entries?
Biotechnology appears in 7 of 17 entries (Solid Biosciences, Phio Pharmaceuticals, DNAiTECH, AssayQuant Technologies, Akoya Biosciences, Meadowhawk Biolabs, plus the remaining biotech-listed companies in the table). Consumer Electronics and Financial Services each appear in multiple entries as well, but biotech is the only sector that reaches a clear majority-style share within this slice.
What does the round stage breakdown suggest when most classifications are missing?
“Series Unknown” appears in 13 of 17 rows, limiting stage-based comparisons. Among the explicit classifications, the disclosed amounts are spread across labels: LiquidStack is Series B at $20M (2024-09-19), OneShield Software is Venture - Series Unknown at $50M (2022-01-27), and Main Street Bank is Debt Financing at $25M (2021-12-03).
Which companies define the upper and lower ends of disclosed funding in this dataset?
The top end is Solid Biosciences at $200M (2025-02-18), followed by OneShield Software at $50M (2022-01-27) and LiquidStack at $20M (2024-09-19). The low end is Special Olympics Massachusetts at $10K (2023-07-12), with other small-but-notable biotech raises like DNAiTECH at $460K (2024-10-21) and Skyscape at $900K (2022-02-15).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.